← All trials
NCT04560894
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 11, 2020
- Primary completion
- Apr 30, 2024
- Completion date
- Sep 30, 2024
- First posted
- Sep 23, 2020
- Last posted
- Nov 13, 2020
- Enrollment
- 621
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sinocelltech Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.